Harbin Medisan Pharmaceutical Co., Ltd. (SHE:002900)

China · Delayed Price · Currency is CNY

9.78

-0.10 (-1.01%)

Jun 11, 2026, 3:04 PM CST

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2019	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Jan '19 Jan 1, 2019	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Production and Sale of Pharmaceuticals	789.42M	1.13B	-	-	-
Production and Sale of Pharmaceuticals Growth	-30.29%	-	-	-	-
Pharmaceutical Industry	-	-	1.14B	1.01B	899.75M
Pharmaceutical Industry Growth	-	-	13.48%	11.97%	-21.47%
Functional Food Industry	-	-	504.53K	-	-
Cosmetics Industry	-	-	-	-	10.64M
Cosmetics Industry Growth	-	-	-	-	-94.33%
Veterinary Industry	-	-	8.94M	679.76K	-
Veterinary Industry Growth	-	-	1215.72%	-	-
Feed Additive Industry	-	-	17.33K	14.82K	-
Feed Additive Industry Growth	-	-	16.89%	-	-
Unallocated Others	-	-	34.09M	20.27M	35.41M
Unallocated Others Growth	-	-	68.22%	-42.77%	518.91%
Total	789.42M	1.13B	1.19B	1.03B	945.80M
Total Growth	-30.29%	-4.58%	15.40%	8.73%	-29.36%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2019	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Jan '19 Jan 1, 2019	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
North-East China	290.35M	520.13M	465.80M	304.29M	287.72M
North-East China Growth	-44.18%	11.66%	53.08%	5.76%	-54.25%
East China	175.84M	167.07M	190.94M	214.07M	230.98M
East China Growth	5.25%	-12.50%	-10.80%	-7.32%	-12.02%
Central China Region	78.98M	96.39M	102.13M	87.19M	66.42M
Central China Region Growth	-18.06%	-5.61%	17.13%	31.27%	-27.93%
Northern China	75.98M	93.10M	108.38M	140.50M	136.11M
Northern China Growth	-18.39%	-14.10%	-22.86%	3.23%	6.42%
South-West	56.98M	76.11M	110.63M	124.84M	97.22M
South-West Growth	-25.13%	-31.20%	-11.39%	28.41%	-12.16%
Southern China	79.61M	92.28M	97.24M	88.35M	79.57M
Southern China Growth	-13.74%	-5.10%	10.07%	11.03%	19.18%
Northwestern Region	20.86M	29.23M	32.95M	29.13M	25.70M
Northwestern Region Growth	-28.64%	-11.30%	13.10%	13.36%	-26.88%
Overseas	10.81M	58.17M	78.71M	40.04M	22.08M
Overseas Growth	-81.41%	-26.10%	96.60%	81.29%	49.33%
Total	789.42M	1.13B	1.19B	1.03B	945.80M
Total Growth	-30.29%	-4.58%	15.40%	8.73%	-29.36%

Source: S&P Global Market Intelligence.